I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Harrington, KJ
134
results:
Search for persons
X
Format
Online (134)
Mediatypes
Articles (Online) (4)
OpenAccess-fulltext (130)
Sorted by: Relevance
Sorted by: Year
?
1
OX40 and 4-1BB delineate distinct immune profiles in sarcom:
Melake, MJ
;
Smith, HG
;
Mansfield, D
...
OncoImmunology. 11 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1080/..
?
2
The effect of parotid gland‐sparing intensity‐modulated rad..:
Richards, TM
;
Hurley, T
;
Grove, L
...
Oral Diseases. 23 (2017) 7 - p. 990-1000 , 2017
Link:
https://doi.org/10.1111/..
?
3
Hickman line practice in patients with solid tumours:
Harrington, KJ
;
Kelly, SA
;
Jackson, JE
.
European Journal of Cancer. 29 (1993) - p. S209 , 1993
Link:
https://doi.org/10.1016/..
?
4
Hyperfractionated intracavitary accelerated radiotherapy (H..:
Kelly, SA
;
Harrington, KJ
;
Harrison, M
...
European Journal of Cancer. 29 (1993) - p. S127 , 1993
Link:
https://doi.org/10.1016/..
?
5
Results and lessons learnt from the WISTERIA phase I trial ..:
Kong, A
;
Kirkham, AJ
;
Savage, JS
...
BJC Reports,. , 2024
Link:
https://repository.icr.a..
?
6
Developing and Validating a Multivariable Prognostic-Predic..:
Mehanna, H
;
Rapozo, D
;
von Zeidler, SV
...
729760. , 2024
Link:
https://repository.icr.a..
?
7
Pembrolizumab versus methotrexate, docetaxel, or cetuximab ..:
Harrington, KJ
;
Cohen, EEW
;
Soulières, D
...
ARTN 106587. , 2024
Link:
https://repository.icr.a..
?
8
Phase 1, open-label, dose-escalation study on the safety, p..:
Rudin, CM
;
Pandha, HS
;
Zibelman, M
...
ARTN e005007. , 2023
Link:
https://repository.icr.a..
?
9
Enhancing anti-tumour innate immunity by targeting the DNA ..:
Chan Wah Hak, CML
;
Rullan, A
;
Patin, EC
...
Frontiers in Oncology, 2022, 12. , 2023
Link:
https://repository.icr.a..
?
10
Immune checkpoint inhibitor therapy and outcomes from SARS-..:
Cortellini, A
;
Dettorre, GM
;
Dafni, U
...
ARTN e005732. , 2023
Link:
https://repository.icr.a..
?
11
Durable responses to ATR inhibition with ceralasertib in tu..:
Dillon, MT
;
Guevara, J
;
Mohammed, K
...
175369. , 2023
Link:
https://repository.icr.a..
?
12
Predicting progression-free survival after systemic therapy..:
Barber, PR
;
Mustapha, R
;
Flores-Borja, F
...
ARTN e73288. , 2023
Link:
https://repository.icr.a..
?
13
Implications of the riverine response to enhanced weatherin..:
Harrington, KJ
;
Hilton, RG
;
Henderson, GM
doi:10.1016/j.apgeochem.2023.105643. , 2023
Link:
https://doi.org/10.1016/..
?
14
Phase 1, open-label, dose-escalation study on the safety, p..:
Rudin, CM
;
Pandha, HS
;
Zibelman, M
...
https://eprints.whiterose.ac.uk/196781/1/Phase%201,%20open-label,%20dose-escalation%20study%20on%20the%20safety,%20pharmacokinetics,%20and%20preliminary%20efficacy%20of%20intravenous%20Coxsacki.pdf. , 2023
Link:
https://eprints.whiteros..
?
15
Predicting progression-free survival after systemic therapy..:
Barber, PR
;
Mustapha, R
;
Flores-Borja, F
...
ELIFE. , 2022
Link:
https://qmro.qmul.ac.uk/..
1-15
